Background {#Sec1}
==========

Globally the burden of typhoid fever victims are 20 million as a main issue of morbidity and mortality in developing countries \[[@CR1], [@CR2]\]. In Sudan, approximate numbers of typhoid infection is increasing during rainy season in association with malaria incidents \[[@CR3]--[@CR5]\]. *Salmonella* Typhi as causative organism has rapidly gained resistance to antibiotics like ampicillin, chloramphenicol and cotrimoxazole, and also to previously effective drugs namely fluoroquinolone \[[@CR6]\]. Resistance to the antimicrobial agents such as trimethoprim--sulfamethoxazole, chloramphenicol and amoxicillin has been increasingly reported among *S.* Typhi isolates. In addition, quinolone resistance has been reported from Southeast Asia and the Indian subcontinent. Determining the patterns of antimicrobial resistance is essential in recommending effective treatment for bacterial infection \[[@CR7], [@CR8]\]. The incidence of multidrug resistant *S*. Typhi was found to be increasing globally and has been a scourge for those afflicted with enteric fever all over the world, while there are many reports noting decline in susceptibility to ciprofloxacin \[[@CR9]\]. Resurgence of resistant Salmonella well-known as increasing to the amount of multi drug resistant strains against nalidixic acid even though the isolates were sensitive to ceftriaxone and ciprofloxacin \[[@CR10]\]. Until now, Ciprofloxacin is a promising antibiotic against numerous bacterial infections, for its ability to penetrate into the macrophages and to kill multidrug-resistant strains \[[@CR11]\]. On the other hand, emergence of resistant Salmonella strains against fluoroquinolone has been reported \[[@CR12]--[@CR14]\]. Since fluoroquinolone has broad spectrum, potency, and oral efficacy, it could be useful for oral treatment of general bacterial infections \[[@CR15]\]. Therefore, it is necessary for susceptibility pattern of the particular strain isolated from patient to be determined by the sensitivity test in vitro \[[@CR16]\]. Variation in patterns of susceptibility of *S*. Typhi is important to monitor it and provide suitable guidelines on fluoroquinolone treatment given as oral tablets that have better absorption from the gastrointestinal tract after oral administration \[[@CR17]\]. Routine investigation for the antibiotics members of fluoroquinolone MICs in patients presenting with invasive Salmonella infections should be done \[[@CR18]\]. However, revealing increased resistance to ciprofloxacin (MICs, 0.125--1 µg/mL/L) had emerged and become endemic in South and South-East Asia, also such strains have also been described from other parts of the globe \[[@CR19], [@CR20]\]. Accordingly, there is treatment collapse of fluoroquinolones in patients infected with these organisms, because isolates with reduced susceptibility to fluoroquinolones might become highly resistant to sequential increasing of mutations in topoisomerase genes \[[@CR21], [@CR22]\]. The prediction of drug efficiency started by the use of uncomplicated screening tools such as implying antibiotic discs are of great value \[[@CR23]\]. For predicting resistance and outbreaks problems, it is essential to create the mathematical time-series incorporate any sort of statistical trend, otherwise by definition forecasting would be impossible \[[@CR24]\]. The application of in silico models' parameters that assessed the estimated efficiency of any antibiotic therapy in specific bacterial population dynamics, required the computational simulation and mathematical data analysis. It also required the possibility to monitor the outbreaks occurrence on the suspected environment and to mark the actual MIC spread values \[[@CR25]\].

Objectives {#Sec2}
----------

This work was conducted to evaluate the recent efficiency of common antibiotics used against *Salmonella* Typhi in Sudan and predict the future trends and fluctuations of susceptibility using inexpensive materials and simple statistical methods to support the decision for antimicrobial choice and dosage especially during rainy season and outbreaks.

Methods {#Sec3}
=======

Isolation of *Salmonella* Typhi {#Sec4}
-------------------------------

Environmental samples collected from wastewaters of Omdurman Military Hospital and Soba Stabilization Station ponds, showed positive numbers of Multidrug *Salmonella* Typhi (n = 128). Laboratory investigations were done immediately after collections include; cultural characteristics and biochemical tests were performed according to the recommendations of \[[@CR26]\] standards. Serotyping was done using polyvalent O-anti sera A--G and H (flagellar)-anti sera formula.

Antibiotic susceptibility {#Sec5}
-------------------------

The antimicrobial susceptibilities of the isolated strains were tested following the Clinical Laboratory Standards Institute guidelines \[[@CR27]\]. The experimented antibiotics were those commonly used for Gram negative bacteria by Kirby Bauer disk diffusion susceptibility test which include; tetracycline (TE~30mcg~), ofloucin (OF~5mcg~), cefroxin (CXM~30mcg~), cotrimoxazole (COT~25mcg~), amoxyclar (AMC~30mcg~), gentamycin (GEN~30mcg~) and ciprofloxacin (Cip~5mcg~). The discs were placed on the top surface of the agar plates, inoculated with *Salmonella* Typhi and incubated overnight at 37 °C. The diameters of inhibition zones were calculated using reference tables to determine whether the bacteria are sensitive (S), intermediate (I) or resistant (R) to the certain antibiotic. A standard *E. coli* strain ATCC 25922 was also tested for quality control \[[@CR28]\].

Determination of minimum inhibition concentration (MIC) {#Sec6}
-------------------------------------------------------

Bacterial suspensions were made in sterile nutrient broth by colonies from a pure cultures and the turbidity adjusted to 0.5 McFarland standards to make a concentration of about 10^7^ CFU/mL. Sensitivity to ciprofloxacin was evaluated by the macro-dilution test according the criteria stipulated by the \[[@CR29]\] with serial Ciprofloxacin dilutions of 8, 16, 32, 64 and 128 µg/mL respectively. Results were recorded as minimum inhibitory concentrations (MIC). A standard *E. coli* strain ATCC 25922 was also tested for quality control.

Determination of minimum bactericidal concentration (MBC) {#Sec7}
---------------------------------------------------------

Following the MICs determination, 100 μL were aspirated from the wells of the micro-plates that showed growth inhibition and then inoculated on the top surface of plates containing Mueller--Hinton agar medium. Plates were incubated overnight and examined visually for bacterial growth. A standard strain *E. coli* ATCC 25922 was also tested for quality control.

Probability of antibiotics resistance (%) {#Sec8}
-----------------------------------------

To determine the thresholds of bacteria resistance to ciprofloxacin, statistical probabilities for MBCs breakpoints were done by trending normal probability plot.

Prediction of antibiotics resistance {#Sec9}
------------------------------------

Time-series prediction (calculated from the current susceptibility pattern) was employed by using simple statistical systems (regression and simple moving average) for the temporal variations in *Salmonella* Typhi sensitivity or resistance towards antibiotics and resulted in (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}). In silico model of outbreak was created for solving the prediction of bacteria resistance due to periodic samples collections \[[@CR30]\].

Results {#Sec10}
=======

Isolation and identification of *S. typhi* {#Sec11}
------------------------------------------

From the recovered bacteria species, 128 were identified as *Salmonella* Typhi, the isolates stereotyping showed that; 9 groups (75%) had the antigenic formula O:9(D~1~) for *Salmonella* Typhi, 3 groups (25%) had the formula *Salmonella enteric* Paratyphi A 1,2,12 a \[[@CR1], [@CR5]\] and *Salmonella enterica* Paratyphi C1 6,7,\[Vi\] c 1,5 respectively.

Antibiotics susceptibility test {#Sec12}
-------------------------------

Different patterns of susceptibility were shown by the 12 *S. typhi* isolated groups for their response against the seven tested antibiotics. *Salmonella* Typhi defined as multi drug resistant when isolate resist two or more tested antibiotics, exceptions were COT~25mcg~, GEN~30mcg~ and Cip~5mcg~ which were susceptible. However, three isolates (S3, S4 and S6) had intermediate resistance to GEN~30mcg~. Eight isolates were resistant to CXM~30mcg~.

Antibiogram or (in vitro-sensitivity) showed susceptibility patterns of *Salmonella* Typhi isolated groups that have developed resistance against most antibiotics (multi drug resistant) including cotrimoxazole, gentamycin and ciprofloxacin and interpreted as MIC ≥ 32 µg/mL.

Minimum inhibitory concentration (MIC) {#Sec13}
--------------------------------------

The MIC of ciprofloxacin against the *S.* Typhi isolated strain and the control *E. coli* strain indicated that two *S.* Typhi *Dr11* and S8 were capable to tolerate ciprofloxacin as high as 32 µg/mL, five (S3, S6, S7, S9 and S10) can grow in 16 µg/mL and four isolates (Dr14, S1, S4 and S5) showed no growth at concentrations higher than 8 µg/mL while isolate S2 could not tolerate any of the tested ciprofloxacin concentrations. Therefore, any isolated strain that showed resistance to ciprofloxacin higher than 16 µg/mL was considered as resistant isolate. The means of (33.0%) of the isolates found to be multi-drug resistant strains and categorized in 8 main groups namely (S. Typhi 16, S. Typhi 32, S.7 16, S.7 32, Dr11 16, Dr11 32, Sal C 16, Sal C 32). The Minimum Inhibitory Concentrations MICs were determined at 16 and 32 µg/mL concentrations, and (67.0%) isolates that resist ciprofloxacin as minimum bactericidal concentration (MBCs).

Minimum bactericidal concentration (MBC) {#Sec14}
----------------------------------------

The MBC breakpoints of the 12 *S.* Typhi and the control *E. coli* can tolerate 32 µg/mL antibiotics indicating an emergence of resistance against this antibiotic that should have more attention.

Probabilities of antibiotics resistance occurrence among (MBCs) {#Sec15}
---------------------------------------------------------------

Statistical analysis between antibiotics' concentrations µg/mL and MBCs breakpoints was done by MBCs trending plot for the probability of resistance occurrence.

According to the data obtained from the tested patterns of susceptibility, the probability of an isolate to develop resistance increases with antibiotics concentration increasement as shown in (Table [1](#Tab1){ref-type="table"}). The determination of Spearman coefficient (R-square) was calculated R^2^ = 0.8568 and its corresponding p value was founded (p = 0.022038522). For the estimation of the regression lines, each of the data points was plotted and weighted by the inverse of the variance and the rate of regression (y = 3.0919e^0.0162x^).Table 1Probabilities of multi drug resistance occurrenceInterpretationCiprofloxacin concentration µg/mLProbability of resistance occurrence %Control0.00S≥8.025I=16.042R≤32.058R≤64.075R≤128.092

The plotted graph showed the percentage probability of MBCs to resist antibiotics concentrations and their empirical observations were solved by$$\documentclass[12pt]{minimal}
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                \begin{document}$$\left( {{\text{y }} = {\text{ nx}}{-}{\text{b}}} \right).$$\end{document}$$The Spearman coefficient of determination was calculated R^2^ = 0.8381 and it corresponds significantly to the rate of resistance occurrence by (y = 0.0235x − 0.0411).

Prediction of antibiotics susceptibility trends {#Sec16}
-----------------------------------------------

The prediction of possible resistance occurrence was statistically estimated by regression and simple moving average for certain period of incubation with antibiotics. The increasing numbers of MBCs equal to the probability of more cells grown with antibiotics and develop resistance during the first 12 h and calculated for the next 7 days of incubation period as shown in (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}).Table 2Prediction of antibiotics resistance interpreted of 16 µg/mLIncubation*E. coli*Dr 11Dr 14S1S2S3S4S5S6S7S8S9S10Actual 12 h6965433566798Day 17956435666799Day 2887554667781011Day 3897654777791212Day 49108755677791212Day 591187656888111313Day 691288768988131413Day 791388768998161514Predicting low-level resistance of antibiotics at 16 µg/mL as intermediate dose among *S.* Typhi is an indicator of treatment failure in the nearest future Table 3Prediction of antibiotics resistance interpreted of 32 µg/mLIncubation*E. coli*Dr 11Dr 14S1S2S3S4S5S6S7S8S9S10Actual 12 h1831211222564Day 11962221232565Day 211074221233675Day 321086321333676Day 421097422333787Day 5310108632343787Day 6411109743343897Day 751211108634548108

Predicting high-level resistance of antibiotics at 32 µg/mL as resisted dose among *S.* Typhi is an indicator of total treatment failure. It is clear that both Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} showed the numbers of resisted colonies have daily developed increasing resistance with no specific pattern.

Minimum bactericidal concentration's predication of *E. coli* ATCC 25922 resistance was given by (y = 6.2391e^0.0513x^) and the coefficient (R^2^ = 0.7). *Salmonella* Typhi, (Dr11, Dr14, S1...S10) were obtained by the exponential trend$$\documentclass[12pt]{minimal}
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The bacteria resistance after long term of incubation period with antibiotics was predicted by (y = n e^x^), where (n) is the numbers of colonies (MBCs) and (e^x^) is the exponent positive integers which corresponds to increasing probabilities of resistance incident at certain time. The predictive coefficient R^2^ value for each isolate of antibiotics concentrations (16 and 32 µg/mL) are shown in (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}).

The solution of the linear equation (y = n e^x^) on plotted Excel sheet solved the prediction of long term incubated bacteria with antibiotics. The predictive patterns of all isolated strain showed increasing in their exponential trends of antibiotics concentrations of 16 and 32 µg/mL which correlate to the increasing probabilities of resistance occurrence (Table [4](#Tab4){ref-type="table"}), the table also showed high values of coefficient R^2^ \> 0.5 and this indicates how well data fit the statistical model.Table 4Results of linear predictive patterns of resistance in *Salmonella* TyphiSample16 µg/mL32 µg/mLExponential trendCoefficientExponential trendCoefficient*E. coli* ATCC 25922y = 6.2391e^0.0513x^R^2^ = 0.7208y = 0.5978e^0.2636x^R^2^ = 0.9455Dr11y = 7.621e^0.0604x^R^2^ = 0.7886y = 8.0752e^0.0458x^R^2^ = 0.9347Dr14y = 5.2505e^0.0676x^R^2^ = 0.7903y = 3.7532e^0.1528x^R^2^ = 0.7738S1y = 4.5725e^0.0717x^R^2^ = 0.9591y = 1.153e^0.3069x^R^2^ = 0.8695S2y = 3.2991e^0.0977x^R^2^ = 0.9339y = 1.1018e^0.2501x^R^2^ = 0.9066S3y = 2.7596e^0.1016x^R^2^ = 0.9254y = 0.7688e^0.2367x^R^2^ = 0.9544S4y = 3.6258e^0.1079x^R^2^ = 0.6979y = 0.7328e^0.172x^R^2^ = 0.9362S5y = 4.8046e^0.0834x^R^2^ = 0.958y = 1.5462e^0.1135x^R^2^ = 0.7652S6y = 5.5536e^0.0552x^R^2^ = 0.8698y = 2.0479e^0.1038x^R^2^ = 0.8484S7y = 5.7606e^0.0459x^R^2^ = 0.884y = 1.8061e^0.0911x^R^2^ = 0.9553S8y = 5.7004e^0.1168x^R^2^ = 0.9397y = 4.5789e^0.0745x^R^2^ = 0.9477S9y = 8.0663e^0.0787x^R^2^ = 0.9797y = 5.2388e^0.0759x^R^2^ = 0.886S10y = 7.7298e^0.0796x^R^2^ = 0.9237y = 3.9538e^0.0955x^R^2^ = 0.9566

In silico simulation for predicting patterns of outbreak {#Sec17}
--------------------------------------------------------

For long term predicting of MDR *Salmonella* Typhi in certain period (5 years) for outbreak purposes, a monitoring simulated system was created from bacteria collected during study period to predict population dynamics especially during rainy season and/or outbreak (Additional file [1](#MOESM1){ref-type="media"}). In ideal microbial community dynamics, the normal bacteria growth rate is given by$$\documentclass[12pt]{minimal}
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Introducing antibiotic to the population gives different interactions of *Salmonella* Typhi and become$$\documentclass[12pt]{minimal}
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Since multidrug resistant *Salmonella* Typhi (N) affected by antibiotics (∆) and denoted by (α) = \[range of C~min~ up to C~max~/MIC\], in time (t), where: N = variations in concentrations of Salmonella population dynamic = (N~0~ − N~t~), t = variations time (t~0~ − t~1~). The MIC and the (α) target values for these indices are 16 and 32, respectively and become (C~16~, C~32~). The (α) elimination of the initial concentration of antibiotics affected bacteria \[resistant − mortality (s − m)\] and E = prediction of multidrug Salmonella resistance outbreak where (N, t ≠ 0).

Changes in these populations depend only on the net growth rate at time (t). Where a, b are positive constants and the initial bacteria N at time (0) = N~0~, If a \> b the bacteria grow exponentially, if a \< b the bacteria die out as shown in (Table [5](#Tab5){ref-type="table"})Table 5Outbreaks' simulation system parametersDescriptionParameterEstimated valueSimulated valueUnitsInitial populationN~0~y = n e^x^1.0000Cell/mLBacteria replication timet(t \> 0)30minBacterial replication raterln x^(+a)^100Mortality of bacteriamln x^(−b)^25Probability to resist antibiotics∆2.00Antibiotics influence doseαC~16~, C~32~2.0 and 5.0µg/mLFinal populationN~t~ln x^(a−b)^2.99573Cell/mLResisted individuals (survived)Nln (x)12Prediction of outbreaksE− 13.00%

It was assumed that resistant bacteria occurred with a constant rate during the whole experimental period. Since different sub-populations resemble patterns of infection-causing inoculums (one highly susceptible with MIC = 2.0 µg/mL, and one more resistant with an MIC = 5.0 µg/mL) that differ not only in EC~max50~ but also in the slope of their relationship to drug concentrations which is simulated as the outcome of treatment regimen illustrated in (Fig. [5](#Fig5){ref-type="fig"}).

Discussion {#Sec18}
==========

The increasing of multi drugs resistant bacteria in Sudan is a real issue and a major concern for all health authorities \[[@CR31]\]. Although massive reports mentioned the increasing of resistance globally but the current patterns of MDR *Salmonella* spp. in Sudan is acceptable \[[@CR32]\]. For effective measuring patterns and predicting of bacteria resistance, a microbial monitoring system was launched for Soba and Omdurman Military Hospital Stabilisation Stations were *Salmonella* Typhi originated from infected humans and survive during treatment at stations' ponds to invade the environment \[[@CR33]--[@CR35]\] have previously reported this epidemiological issue. The system was effectual for collections of samples especially during rainy seasons when outbreaks were expected; these agreed with \[[@CR36]\] who also highlighted the hazard of scattering resistant Salmonella strains from wastewater to the environment and infect humans again. Fourth generation Fluoroquinolone antibiotics are commonly used in Sudan to treat a variety of illnesses such as respiratory and urinary tract infections \[[@CR37]--[@CR39]\]. These antibiotics were tested and the proposed breakpoints were calculated with a standard *E. coli* ATCC 25922 reference as the Clinical and Laboratory Standards Institute (CLSI) recommendation for quality control, this in agreement with \[[@CR28], [@CR40], [@CR41]\]. Interpretation of antibiotics' susceptibility for *Salmonella* Typhi include ciprofloxacin, gemifloxacin, levofloxacin, moxifloxacin, norfloxacin, and ofloxacin showed sensitive pattern of cotrimoxazole, gentamycin and ciprofloxacin to all isolated strain (Fig. [1](#Fig1){ref-type="fig"}) and resistance to some of the others, this agreed \[[@CR42]--[@CR44]\] who reported similar results of Ciprofloxacin susceptibility pattern for *Salmonella* Paratyphi indicating their sensitivity as antimicrobial. Statistical explanation of antibiogram indicated regular pattern of susceptibility by determining MICs and MBCs breakpoints of the isolated strains at (16 µg/mL) as threshold, the result agreed \[[@CR45]\] and explained by \[[@CR46], [@CR47]\], when the isolated strain become more tolerant to the antibiotics they showed higher MICs without new mutation after 8 µg/mL. Moreover, probability trends in the MIC or its resultant MBC distribution above the threshold may not be observed whereas the distribution to the left of the threshold is not expected to change over time \[[@CR48]\]. When such changes in the resistant isolated strain are expected then the ordinal or quantitative scale of distribution trends needs to be considered as confirmed by \[[@CR49]\]. The probability of *Salmonella* Typhi resistance may occur during the course, and it can be plotted as linear equation (Eq. [1](#Equ1){ref-type=""}), where the coefficient of isolated strain found to be resistant as calculated in (Fig. [2](#Fig2){ref-type="fig"}), \[[@CR50]\] reported the application of related antibiotics such as (beta-lactam antibiotics and macrolides) and the log odds of resistance could be modelled in the course of linear regression where a strong linear and statistically significant relationship is confirmed. The in vitro prediction of resistance trends demonstrated that the scale of the impact was relatively more influential for cotrimoxazole, gentamycin and ciprofloxacin, (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}), \[[@CR51]\] identifying the MIC of antimicrobial agent is an effective assessment for clinical success using breakpoints determination for predicting and detecting the probability of resistant populations during specific timeline. The emergence of resistance pattern could be predicted by changing the values from actual to forecast in the time-line of the experiment (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}) depending on bacteria exponential growth during antibiotics course (Eq. [2](#Equ2){ref-type=""}), reports from \[[@CR52]--[@CR54]\] confirmed that; various antimicrobial agents are related to the emergence of resistance during prolonged therapy. Consequently, isolated strains that are originally susceptible may become resistant within three to 4 days after the beginning of treatment \[[@CR55]\]. Conversely, the previous records of rapid emergence of resistance to recently introduced antibiotics indicates that even new families of antibiotics will have a short life expectancy \[[@CR56]\], to avoid this critical issue, a predictive system was created and applied during collection of samples. Earlier information of antibiotic's efficiency in treating a bacterial infection can potentially play a major role in controlling serious outbreaks \[[@CR57], [@CR58]\], the long-term prediction of bacterial population and antibiotics dynamics was modelled (Eqs. [3](#Equ3){ref-type=""} and [4](#Equ4){ref-type=""}) using such information. Therefore, the purpose of in silico simulation models as shown in (Table [4](#Tab4){ref-type="table"}) for this research is to observe the seasonal typhoid incidents computationally because it is essential to predict the outcome of their trended outbreaks as reported by \[[@CR59]\]. To control a successful strategy of a typical disease scenario (Fig. [5](#Fig5){ref-type="fig"}), the measure plan is to eliminate the causative bacteria before it has the opportunity to spread and infect more population. However, modelling is essential in drug development for certain pathogenic population, and it contains many complex processes that require robust of basic procedures for predicting clean data, fitting computing platforms, sufficient resources, and valuable communication. Absolutely, the application of model-based approaches for drug development and for maximizing the clinical potential of drugs is a complex and developing field, precisely in silico models that have considerable attention during outbreaks because they are essential for connecting pharmacokinetics information and clinical outcomes \[[@CR60]\].Fig. 1Antibiogram criteria for multi-drug resistant strains Fig. 2Antibiotics normal probability plot Fig. 3Prediction of antibiotics MBC resistance's trends at 16 µg/mL Fig. 4Linear predicition of antibiotics MBC resistance's trends at 32 µg/mL Fig. 5In silico simulations of MDR *Salmonella* Typhi outbreaks. The in silico monitoring system is a computational program based on Microsoft Excel sheet describes the predicting statistics was found to be suitable for monitoring the seasonal typhoid incidents during the outbreaks

Conclusion {#Sec19}
==========

The present patterns of ciprofloxacin susceptibility are in normal ranges. This study assesses the prediction of multi-drug resistance among *S*. Typhi isolates by applying low cost materials and simple statistical methods suitable for the most frequently used antibiotics as experimental therapy. Consequently, bacterial surveillance systems were implemented to present data on the aetiology and current antimicrobial drug resistance patterns of community-acquired agents causing bacteraemia and outbreaks.

Additional file {#Sec20}
===============

**Additional file 1.** Prediction of MDR *Salmonella* Typhi Simulations.
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